CClinicalTrials.gg
CompletedNCT01325727Updated Nov 15, 2012

Brief Computerized Feedback for Smokers in Recovery

An interventional study of Brief computerized feedback and Resources only (control) in Smoking, sponsored by Virginia Commonwealth University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-11-15.

Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
151
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research study is to find out more about smokers in recovery from addiction to alcohol/other drugs, and to evaluate a brief computerized smoking behavior feedback session. The hypothesis is that a brief computerized smoking behavior feedback session will motivate more smokers to quit smoking than a control condition.

02

Conditions studied

  • Smoking
03

In context

Lead sponsor

Virginia Commonwealth University is the lead sponsor of 641 studies on the registry; 82 are open to participants now.

Of its 88 completed or terminated interventional studies of FDA-regulated products, 62 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  1. Be 18 years of age or older
  2. Be in recovery from addiction to alcohol and/or drugs (self-defined)
  3. Have smoked at least one cigarette per day for the past seven days or at least 10 cigarettes total during the past week
  4. Have smoked at least 100 cigarettes (lifetime)
  5. Have an expired air carbon monoxide (CO) level of > 6 ppm (verifies current smoking)
  6. Be cognitively able to understand the proposed research design (screening followed by random assignment to one of the two conditions, if appropriate)

To be eligible to receive NRT (if chosen by the participant), participants must:

  1. Not be pregnant, breastfeeding, or plan to become pregnant in the next year
  2. Not have experienced a myocardial infarction (heart attack) or have been hospitalized for a heart-related problem in the last 2 weeks
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
151 participants (actual)

Study arms

  • Experimental
    Brief computerized feedback

    Brief computerized feedback

    Other: Brief computerized feedback

  • Active comparator
    Resources only

    Other: Resources only (control)

Interventions

  • OtherBrief computerized feedback

    Brief computerized feedback

  • OtherResources only (control)

    Participants randomized to the control group will discuss the option of quitting smoking, along with an information sheet, highlighting resources available to assist participants with smoking cessation, such as the Virginia Quitline (1-800 QUIT NOW) and nicotine replacement therapy.

06

What researchers measure

Primary outcomes

  1. % quit smoking

    Time frame: 4 weeks

07

Study locations

1 site
  • Substance Abuse Addiction and Recovery Alliance Center
    Midlothian, Virginia 23225, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 15, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01325727
Lead sponsor
Virginia Commonwealth University
Responsible party
Sponsor
First posted
Mar 30, 2011
Start date
Mar 2011
Primary completion
Nov 2012
Completion
Nov 2012
Last update
Nov 15, 2012

Study contacts

Alison Breland, PhD
principal investigator · Virginia Commonwealth University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion